If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com).  The website is updated approximately twice a month.

PDP Press Releases/ statements

IAVI 

• 5 Aug: ENABLE project launches to evaluate the enhancement of treatment of HIV in infants by adding monoclonal antibodies

IVCC

 • 1 Oct: Sustaining the UK’s malaria science leadership at Labour Party Conference

• 7 Oct: Malaria Science Index highlights the importance of investment and partnerships in malaria innovation

TB Alliance

• 5 Oct: TB Alliance Announces Three Leadership Appointments

• 7 Oct: TB Alliance Launches Creator Collective to Highlight TB In the Global Conversation

GARDP 

• 22 Jul: Last-resort antibiotics remain out of reach in Latin America and the Caribbean, review warns

Population Council

 • 4 Feb: Contraline and Population Council Execute Global Exclusive License Agreement for NES/T Male Contraception Gel

PATH

• 3 Sep: New SARS-CoV-1 antibody available for vaccine researchers

MMV

• 15 Oct: MMV and deepmirror recognized in TIME’s Best Inventions 2026

• 20 Oct: MMV recognized as a “Very High Performer” in the Global Health 50/50 Gender & Health Index for fifth consecutive year

• 23 Oct: African healthcare providers favour a long-acting injectable to simplify malaria prevention

DNDi

• 6 Oct: Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa

• 9 Oct: DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness

FIND

•  8 Oct: FIND Board appoints Dr Jutta Reinhard-Rupp as FIND’s Chief Executive Officer

IVI

• 3 Sep: IVI and Karolinska Institutet sign Memorandum of Understanding to strengthen existing cooperation in vaccine research and education

EVI

• 6 Sep: Prof. Umberto D'Alessandro joins EVI as Medical Director

MDGH

• 29 Sep: First participant enrolled in a Phase 3 clinical trial of moxidectin for lymphatic filariasis and other neglected tropical diseases in Fiji

PDP Funder News/Announcements

• 2 Sep: Introducing the New Leader of Our Work on Global Health and Development Policy. Coefficient Giving

• 10 Sep: [Tanzania: Implementation study site report] Tackling Schistosomiasis in the STEPPS Project. GHIT

• 14 Sep: Wellcome CEO joins leaders warning the window for global health reform is closing. Wellcome

• 16 Sep: GHIT Fund Launches “NTDpedia” to Help Turn Apathy into Action Against Neglected Tropical Disease. GHIT

• 20 Oct: Republic of Korea backs Unitaid with US$13 million to advance health innovation and pandemic preparedness. Unitaid

Funder Announcement Archives

     •     2014 PDP Funder Announcements

     •     2013 PDP Funder Announcements

New PDP Publications

•  11 Oct: Research, innovation and product development in the evolving global health ecosystem: an essential global public good. Numerous PDPs

•  12 Oct: What is the future of product development?. Numerous PDPs

Other Reports/ Publications

• 21 Oct: Pipeline Report » 2026 Tuberculosis Vaccines. TAG

• 13 Mar: From Commitments to Action: Practical Pathways for Health Financing in Africa. Global Health Strategies

Related Press Releases/ Announcements/Articles

• 1 Oct: Commentary: Global health research makes America richer and healthier. University of Michigan Health

• 1 Oct: Sluggish donor response to CEPI’s pandemic prevention ask. Development Today

• 1 Oct: Can Africa make 60% of its vaccines by 2040? That’s a tall order, as the travails of South African companies show. Science

• 1 Oct: Symptom-agnostic endpoints in tuberculosis vaccine efficacy trials. The Lancet

• 1 Oct: Early lessons from lenacapavir PrEP roll-out in Zimbabwe. The Lancet HIV

• 1 Oct: Innovation can only be as strong as the systems that deliver it. Devex

• 2 Oct: Beyond diagnostic accuracy: defining the role of tongue swabs in decentralised tuberculosis screening. The Lancet

• 2 Oct: Addressing mosquito-borne disease trends as climate change bites. MedicalXpress

• 3 Sep: Closing the preparedness gap: moving beyond emergency response to sustain the medical countermeasure ecosystem. The Lancet

• 3 Sep: Ebola Outbreak ‘Still Evolving’ as Deaths Pass 3,000. Health Policy Watch

• 3 Sep: WHO grants Emergency Use Listing for Cepheid's Xpert® Hemorrhagic Fever Panel test to support Ebola outbreak response in the DRC. Financial Times

• 3 Oct: Inside the study for a remedy to fight Congo's deadliest Ebola outbreak. PBS

• 4 Sep: KI and IVI strengthen their collaboration in global health. Karolinska

• 4 Sep: Aspen opts not to make HIV prevention jab lenacapavir. Business Day

• 5 Oct: Opinion: Fostering affordable and equitable biomedical innovation. Business Line

• 6 Oct: Three Questions the Bundibugyo Ebola Outbreak Asks of CEPI’s 100 Days Mission. Geneva Health Files

• 6 Oct: Uganda launches Phase I clinical study of Bundibugyo virus disease vaccine. LSHTM

• 8 Sep: Global health reform is missing a generation. The Lancet

• 7 Oct: H.I.V. Research Networks Face Uncertain Future Amid Funding Delays. The New York Times

• 8 Sep: Meet 4 people who got the HIV prevention jab. Bhekisisa  

• 8 Oct: How a new long-acting HIV drug combo tackles resistance. MedicalXpress

• 8 Oct: Why is dengue spreading while malaria has declined?. News Medical

• 8 Oct: NIH revives network to study emerging diseases—but its new restrictions baffle scientists. Science

• 9 Sep: Gavi’s vaccine transition was never about RFK's fixation on mercury. Devex

• 9 Oct: Germany Hosts the World Health Summit, But Has No Plan for the World’s Health. Health Policy Watch

• 9 Oct: Is the global health architecture reform progressing?. Global Public Health Insights

• 10 Oct: Beyond the Breakthrough: Why New HIV Prevention Needs a Delivery Revolution for Girls. SHRM

• 10 Oct: 50 years of Ebola research and response. The Lancet

• 10 Sep: Nigeria achieves historic milestone as Health Textiles Nigeria begins manufacture of Vestergaard’s PermaNet® Dual mosquito nets. Vestergaard

• 11 Sep: Senegal launches pilot study on schistosomiasis treatment for preschool-aged children in Kédougou region. UNDP

• 12 Oct: Final preparations underway for pivotal Phase 2/3 Bundibugyo vaccine trial. CEPI

• 12 Oct: Why scientific breakthroughs won't end HIV if communities are left behind. The Advocate

• 12 Oct: Exclusive: Global Fund eyes new funding mechanism for malaria. Devex

• 13 Oct: With Only Three ‘No’ Votes, UN Adopts Political Declaration on Pandemic Preparedness. Health Policy Watch

• 13 Oct: Mosquito-based malaria control through genetic, microbial and immunological innovations. Nature

• 14 Oct: Innovative roadmaps for sustainable antimicrobial resistance interventions. Science

• 14 Oct: Mosquito saliva study opens new doors for blocking Zika, dengue, and West Nile infections. News Medical

• 14 Oct: Ebola vaccine triggers cross reactive T cells against Bundibugyo ebolavirus. News Medical

• 15 Oct: HIV finds escape routes from a preventive antibody—but newer antibodies may close them. MedicalXpress

• 15 Oct: Good gut bacteria vs bad: what we learnt about antibiotic resistance from a community in Nairobi. The Conversation

• 15 Oct: Medicines for Malaria Venture and Deepmirror dd4gh. Time Magazine

• 15 Oct: Public and private funders inject €159 million in global health research. Science Business

• 15 Oct: Africa’s Pooled Procurement Mechanism Seeks to Lower Medical Product Costs. Africa CDC

• 15 Oct: Cross-neutralisation of authentic Ebola virus and Bundibugyo virus following natural infection or Ervebo vaccination. The Lancet

• 16 Oct: Continuity Biosciences Secures $9.6M Gates Foundation Grant to Advance Multi-Year HIV Prevention Implant. BioPharma

• 16 Oct: Vaccine target of 100 days isn’t fast enough, says CEPI chair—while expert warns of failure to provide basic care in DRC Ebola outbreak. BMJ

• 16 Oct: CEPI and World Bank Group partner to strengthen sustainable vaccine manufacturing in ASEAN. CEPI

• 16 Oct: World Health $ummit: The Necessary Evil of Capitalist Global Health?. IHP

• 16 Oct: First participants vaccinated with Oxford's CEPI-backed Lassa shot in Ghana. CEPI

• 16 Oct: Resetting global health: sovereignty must strengthen rights, not replace them. BMJ

• 16 Oct: Funding cuts threaten to stall global health innovations. Devex

• 17 Sep: Building sustainable diagnostic ecosystems for global health. Nature

• 18 Sep: Global health reform and last-mile integration: the missing link in pandemic preparedness. Gavi

• 18 Sep: New TB vaccines could avert millions of deaths, LSHTM modelling suggests. LSHTM

• 18 Oct: Ebola vaccine trials 'reason for hope' in DR Congo and beyond. RFI

• 18 Sep: Institute of Philanthropy Commits Nearly US$5 Million to Bring Innovative TB Diagnostics Closer to Patients. The Global Fund

• 18 Sep: US Medicare Pricing Policies Could Drive Global Costs and Hinder Access Worldwide. Health Policy Watch

• 18 Sep: PAHO, Gilead deal expands lenacapavir access for 14 countries. Devex

• 18 Sep: Coefficient Giving launches $165M fund to help countries navigate aid cuts. Devex

• 19 Oct: Global Health Research in the America First Era. Think Global Health

• 19 Oct: AI firm Anthropic to commit 5% of shares to fund for ‘public good’. The Guardian

• 19 Oct: How WHO's pandemic hub plans to identify all new threats within 24 hours. Devex

• 20 Oct: Devex CheckUp: Is a consensus forming around the future of global health?. Devex

• 20 Oct: A.I. Fortunes Could Bring Critical Funds to Global Health. The Scramble Is On. The New York Times

• 20 Oct: As Ebola epidemic rages, Congo bets on high-stakes ‘hope’ vaccine trial. Science

• 20 Oct: New TB vaccines are coming. How are countries preparing for the rollout?. Gavi

• 20 Oct: Is tuberculosis eradication actually in sight?. Devex

• 21 Oct: African trial optimises dose of drug with potential to improve outcomes in children with severe malaria. Imperial College

• 21 Oct: Now What with Injectable LEN for PrEP? How to Translate Ambition into Accelerated Delivery and Impact. AVAC

• 21 Oct: Sevuparin in children with severe malaria: a phase I safety and dose-finding trial. Nature

• 21 Oct: Drug-resistant infections linked to $3.5 trillion in global economic losses in 2021. CIDRAP

• 22 Oct: Gavi and UNICEF secure lower malaria vaccine price, saving US$ 50 million for childhood immunisation programmes. Gavi

• 22 Oct: A five-year look into how a malaria vaccine changed Ghana. The World

• 22 Oct: African health manufacturers need reliable buyers, not just investment. Devex

• 22 Oct: Global health deserves better criticism. The Lancet Global Health

• 22 Oct: UNICEF and Gavi agree to cut Mosqivac malaria vaccine price by 40%. Reuters

• 23 Oct: First participant vaccinated in pivotal Phase 2/3 Bundibugyo vaccine trial in DRC. CEPI

• 23 Oct: How viruses hijack mosquito saliva to help them infect us. Gavi

• 23 Oct: Long-acting injected combo drug keeps HIV in check, real-world study finds. CIDRAP

• 24 Sep: Malaria parasite can reawaken after years: New vaccine target may block liver infection. MedicalXpress

• 24 Sep: Fractured ecosystems, climate change raise risk of zoonotic, vector-borne disease outbreaks, study finds. CIDRAP

• 24 Sep: Diagnostic performance and testing costs of pooled testing for molecular detection of tuberculosis in seven countries: a prospective, observational, diagnostic accuracy study. The Lancet

• 25 Sep: What the NIH cuts really mean for global health. Impact for Global Health

• 25 Sep: Targeted HIV drug resistance testing moves into routine care in South Africa. MedicalXpress

• 25 Sep: UN Declaration on Pandemic Readiness Appears Headed for General Assembly Approval. Health Policy Watch

• 25 Sep: There's a global pandemic treaty that's signed — and in 'limbo.' What's the holdup?. NPR

• 25 Sep: World leaders renew commitment to protect the world from future pandemics. WHO

• 25 Sep: New tool to mutate phages boosts the fight against superbugs. NewsMedical

• 26 Oct: Strengthening Africa’s outbreak-ready evidence generation capabilities. CEPI

• 26 Sep: Platform trials: the study design transforming infectious diseases. The Lancet

• 26 Sep: The Accra Reset must turn sovereignty into country power. The Lancet

• 27 Oct: New EU-funded project to advance rapid diagnosis of childhood infections in Africa. Imperial

• 27 Oct: The New TB Vaccines Are Coming! How Can We Prepare for the Rollout?. Gavi

• 28 Sep: Following the Best Science Does Not Always Make the Best Vaccine Investment. CGD

• 28 Sep: From the first vaccines against malaria to the first WHO-approved primary clinical trials registry in Africa: the AU-EU R&I Cooperation delivering in Public Health. Delegation of the EU to African Union

• 28 Sep: Financial Boost for Global Health on Sidelines of UN General Assembly. Health Policy Watch

• 29 Sep: UK rabies vaccine trial could also unlock protection against Disease X. CEPI

• 30 Sep: Made in Africa: New measles rapid diagnostic tests mark breakthrough for vaccination efforts. Gavi

• 30 Sep: How to spend $25 billion on science: OpenAI’s staggeringly rich research charity gets under way. Nature

• 30 Sep: Tuberculosis treatment has advanced — now we need to stop drug resistance dragging us backwards. Nature

Upcoming Meetings/  Webinars

--------------------------